SHIP-1 negatively regulates the PI3K pathway in hematopoietic cells and has an emerging role in T lymphocyte biology. PI3K and SHIP can regulate cell migration in leukocytes, particularly in neutrophils, although their role in T cell migration has been less clear. Therefore, we sought to explore the role of SHIP-1 in human CD4(+) T lymphocyte cell migration responses to chemoattractants using a lentiviral-mediated expression system and a short hairpin RNA approach. Silencing of SHIP-1 leads to increased basal phosphorylation of protein kinase B/Akt and its substrate GSK3?, as well as an increase in basal levels of polymerized actin, suggesting that SHIP-1 might regulate changes in the cytoskeleton. Accordingly, silencing of SHIP-1 led to lo...
PI3K signalling is required for activation, differentiation, and trafficking of T cells. PI3Kδ, the ...
SHIP1 (SH2 domain containing inositol-5ʼ-phosphatase) is a negative regulator of the phosphatidylin...
Of the 25% of T-cell acute lymphoblastic leukemia (T-ALL) patients who relapse or do not respond to ...
SHIP-1 negatively regulates the PI3K pathway in hematopoietic cells and has an emerging role in T ly...
The phosphoinositide 3-kinase signaling pathway regulates a range of T lymphocyte cellular functions...
The leukemic T cell line Jurkat is deficient in protein expression of the lipid phosphatases Src hom...
SHIP1 [SH2 (Src homology 2)-containing inositol phosphatase-1], an inositol 5-phosphatase expressed ...
PI3Ks have been shown to have many important functions in T cells, including in cell growth and surv...
The phosphoinositide 3-kinase signaling pathway has been implicated in a range of T lymphocyte cellu...
The phosphatidylinositol (PI)-3 kinase (PI3K) pathway plays a central role in regulating many biolog...
The SH2-containing inositol-5'-phosphatase, SHIP, has been shown, by comparing SHTP+/+ and -/- cells...
The PI3K (phosphoinositide 3-kinase) family of lipid kinases regulate cell motility in diverse organ...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P-3) signaling pathways...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
Efficient adaptive immune responses require the localization of T lymphocytes in secondary lymphoid ...
PI3K signalling is required for activation, differentiation, and trafficking of T cells. PI3Kδ, the ...
SHIP1 (SH2 domain containing inositol-5ʼ-phosphatase) is a negative regulator of the phosphatidylin...
Of the 25% of T-cell acute lymphoblastic leukemia (T-ALL) patients who relapse or do not respond to ...
SHIP-1 negatively regulates the PI3K pathway in hematopoietic cells and has an emerging role in T ly...
The phosphoinositide 3-kinase signaling pathway regulates a range of T lymphocyte cellular functions...
The leukemic T cell line Jurkat is deficient in protein expression of the lipid phosphatases Src hom...
SHIP1 [SH2 (Src homology 2)-containing inositol phosphatase-1], an inositol 5-phosphatase expressed ...
PI3Ks have been shown to have many important functions in T cells, including in cell growth and surv...
The phosphoinositide 3-kinase signaling pathway has been implicated in a range of T lymphocyte cellu...
The phosphatidylinositol (PI)-3 kinase (PI3K) pathway plays a central role in regulating many biolog...
The SH2-containing inositol-5'-phosphatase, SHIP, has been shown, by comparing SHTP+/+ and -/- cells...
The PI3K (phosphoinositide 3-kinase) family of lipid kinases regulate cell motility in diverse organ...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P-3) signaling pathways...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
Efficient adaptive immune responses require the localization of T lymphocytes in secondary lymphoid ...
PI3K signalling is required for activation, differentiation, and trafficking of T cells. PI3Kδ, the ...
SHIP1 (SH2 domain containing inositol-5ʼ-phosphatase) is a negative regulator of the phosphatidylin...
Of the 25% of T-cell acute lymphoblastic leukemia (T-ALL) patients who relapse or do not respond to ...